NuGen Medical Devices Inc.

NGMDF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$5,226-$9,362-$5,578-$7,107
Dep. & Amort.$646$691$652$791
Deferred Tax$7$34$3$3
Stock-Based Comp.$95$1,364$432$1,308
Change in WC-$340-$726$604-$228
Other Non-Cash$105$1,285$1,756$1,138
Operating Cash Flow-$4,714-$6,714-$2,131-$4,095
Investing Activities
PP&E Inv.-$10-$3-$1-$4
Net Acquisitions$0$0$0$5
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$2-$50$0$0
Investing Cash Flow-$12-$53-$1$2
Financing Activities
Debt Repay.$9,972-$871-$84$75
Stock Issued$0$6,580$673$5,509
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$1,235$1,392-$75$0
Financing Cash Flow$11,207$7,101$514$5,584
Forex Effect$0$0$0-$17
Net Chg. in Cash$6,482$333-$1,618$1,473
Supplemental Information
Beg. Cash$464$131$1,750$276
End Cash$6,946$464$131$1,750
Free Cash Flow-$4,724-$6,717-$2,132-$4,099